207 related articles for article (PubMed ID: 12947087)
21. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
[TBL] [Abstract][Full Text] [Related]
22. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts.
Quan T; He T; Voorhees JJ; Fisher GJ
J Biol Chem; 2005 Mar; 280(9):8079-85. PubMed ID: 15579469
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
[TBL] [Abstract][Full Text] [Related]
24. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling.
Sano Y; Harada J; Tashiro S; Gotoh-Mandeville R; Maekawa T; Ishii S
J Biol Chem; 1999 Mar; 274(13):8949-57. PubMed ID: 10085140
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway.
Vageli D; Ioannou MG; Koukoulis GK
Oncol Res; 2009; 17(9):413-23. PubMed ID: 19718948
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer.
Dowdy SC; Mariani A; Reinholz MM; Keeney GL; Spelsberg TC; Podratz KC; Janknecht R
Gynecol Oncol; 2005 Feb; 96(2):368-73. PubMed ID: 15661223
[TBL] [Abstract][Full Text] [Related]
28. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
Boyer Arnold N; Korc M
J Biol Chem; 2005 Jun; 280(23):21858-66. PubMed ID: 15811853
[TBL] [Abstract][Full Text] [Related]
29. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
[TBL] [Abstract][Full Text] [Related]
30. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.
Tsunobuchi H; Ishisaki A; Imamura T
Biochem Biophys Res Commun; 2004 Apr; 316(3):712-9. PubMed ID: 15033458
[TBL] [Abstract][Full Text] [Related]
31. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation.
Stopa M; Anhuf D; Terstegen L; Gatsios P; Gressner AM; Dooley S
J Biol Chem; 2000 Sep; 275(38):29308-17. PubMed ID: 10887185
[TBL] [Abstract][Full Text] [Related]
32. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
[TBL] [Abstract][Full Text] [Related]
33. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
Nagarajan RP; Chen F; Li W; Vig E; Harrington MA; Nakshatri H; Chen Y
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):591-6. PubMed ID: 10839991
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK.
Jono H; Xu H; Kai H; Lim DJ; Kim YS; Feng XH; Li JD
J Biol Chem; 2003 Jul; 278(30):27811-9. PubMed ID: 12734193
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta1 induces nuclear export of inhibitory Smad7.
Itóh S; Landström M; Hermansson A; Itoh F; Heldin CH; Heldin NE; ten Dijke P
J Biol Chem; 1998 Oct; 273(44):29195-201. PubMed ID: 9786930
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways.
Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF
J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024
[TBL] [Abstract][Full Text] [Related]
38. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A.
Wu J; Janknecht R
J Biol Chem; 2002 Nov; 277(45):42669-79. PubMed ID: 12213813
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7.
Yanagisawa M; Nakashima K; Takeda K; Ochiai W; Takizawa T; Ueno M; Takizawa M; Shibuya H; Taga T
Genes Cells; 2001 Dec; 6(12):1091-9. PubMed ID: 11737269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
